Alzheimer’s treatment lecanemab too costly for NHS, says NICE draft guidance The National Institute for Health and Care Excellence has determined that the small benefit that lecanemab provides patients in the early stages of Alzheimer’s disease does not justify the cost to the NHS.…
Number of overseas pharmacists applying to work in UK falls by two-thirds in one year Exclusive: The fall follows a big increase in overseas-qualified pharmacists applying to the Overseas Pharmacists Assessment Programme in the previous year.…
Registration assessment will be held online until at least 2029, says GPhC The regulator said it was undertaking a procurement process “to provide certainty in relation to delivering the registration assessment” while it considers its future.…
Is the General Pharmaceutical Council making progress to improve its fitness-to-practise processes? A closer look at measures being put in place to alleviate the rapid growth of fitness-to-practise concerns, an issue the pharmacy regulator has dubbed an “unprecedented challenge”.…
Nearly 900 students dropped out of MPharm after first year in 2021/2022 Exclusive: General Pharmaceutical Council data suggest that 889 out of 4,505 students did not continue the MPharm degree after the first year.…
GPhC to add net zero targets into its pharmacy regulatory processes The regulator has outlined plans to include environmental sustainability in its standards for pharmacy professionals and registered pharmacy premises, with its full action plan to be published later in August 2024.…
One-year route to registration for overseas qualified pharmacists proposed by regulator The registration route would initially apply to non-European Economic Area and non-European Free Trade Association qualified pharmacists.…
Latest Medicine, Ethics and Practice includes expanded sections on prescribing and valproate safety The 47th edition contains additional information on prescribing and patient safety to reflect the Society’s “ongoing commitment to high standards of professional practice”.…
GPhC reveals lowest summer registration assessment pass rate for five years The exam results showed a pass rate of 75%, down from the 77% pass rate for the 2023 summer assessment.…
MHRA approves capivasertib for treatment of advanced breast cancer Capivasertib is an oral pill given with fulvestrant, a hormonal therapy, as an alternative treatment to endocrine-based regimens.…
